Microbot Medical CEO to speak at SAGES NBT Innovation Weekend panel on endovascular robotics

Microbot Medical Inc.

CEO Harel Gadot will be a featured panelist at The Surgical Disruptive Technology Summit (Feb 19-21, 2026 in Houston, TX).
Panel titled 'Endovascular Therapeutics: AI and Robotics' to highlight the LIBERTY Endovascular Robotic System.
LIBERTY is FDA cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
Limited market release commenced in late 2025; full market release planned at SIR conference in April 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.